nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—Central Nervous System Stimulation—Methamphetamine—obesity	0.232	1	CiPCiCtD
Dextroamphetamine—narcolepsy—Methamphetamine—obesity	0.0782	0.533	CpDpCtD
Dextroamphetamine—Diethylpropion—obesity	0.0572	0.243	CrCtD
Dextroamphetamine—Phenylpropanolamine—obesity	0.0555	0.236	CrCtD
Dextroamphetamine—Phentermine—obesity	0.0472	0.201	CrCtD
Dextroamphetamine—Methamphetamine—obesity	0.0421	0.179	CrCtD
Dextroamphetamine—attention deficit hyperactivity disorder—Methamphetamine—obesity	0.0343	0.234	CpDpCtD
Dextroamphetamine—attention deficit hyperactivity disorder—Bupropion—obesity	0.0343	0.234	CpDpCtD
Dextroamphetamine—Benzphetamine—obesity	0.0334	0.142	CrCtD
Dextroamphetamine—TAAR1—Methamphetamine—obesity	0.0309	0.184	CbGbCtD
Dextroamphetamine—SLC18A2—Benzphetamine—obesity	0.0151	0.0895	CbGbCtD
Dextroamphetamine—SLC18A2—Methamphetamine—obesity	0.012	0.0716	CbGbCtD
Dextroamphetamine—SLC6A3—Diethylpropion—obesity	0.00989	0.0588	CbGbCtD
Dextroamphetamine—SLC6A3—Sibutramine—obesity	0.00749	0.0445	CbGbCtD
Dextroamphetamine—SLC6A3—Phendimetrazine—obesity	0.00749	0.0445	CbGbCtD
Dextroamphetamine—SLC6A2—Diethylpropion—obesity	0.00724	0.043	CbGbCtD
Dextroamphetamine—Tranylcypromine—Phendimetrazine—obesity	0.00677	0.0428	CrCrCtD
Dextroamphetamine—ADRA1B—Phendimetrazine—obesity	0.00601	0.0357	CbGbCtD
Dextroamphetamine—SLC6A3—Phentermine—obesity	0.00568	0.0338	CbGbCtD
Dextroamphetamine—SLC6A3—Benzphetamine—obesity	0.00568	0.0338	CbGbCtD
Dextroamphetamine—SLC6A2—Sibutramine—obesity	0.00548	0.0326	CbGbCtD
Dextroamphetamine—SLC6A2—Phendimetrazine—obesity	0.00548	0.0326	CbGbCtD
Dextroamphetamine—SLC6A3—Phenylpropanolamine—obesity	0.00542	0.0322	CbGbCtD
Dextroamphetamine—SLC6A3—Bupropion—obesity	0.00483	0.0287	CbGbCtD
Dextroamphetamine—ADRA1A—Phendimetrazine—obesity	0.00474	0.0282	CbGbCtD
Dextroamphetamine—SLC6A3—Methamphetamine—obesity	0.00454	0.027	CbGbCtD
Dextroamphetamine—SLC6A2—Benzphetamine—obesity	0.00416	0.0247	CbGbCtD
Dextroamphetamine—SLC6A2—Phentermine—obesity	0.00416	0.0247	CbGbCtD
Dextroamphetamine—Tranylcypromine—Phenylpropanolamine—obesity	0.0041	0.0259	CrCrCtD
Dextroamphetamine—SLC6A2—Phenylpropanolamine—obesity	0.00397	0.0236	CbGbCtD
Dextroamphetamine—ADRA1A—Benzphetamine—obesity	0.00359	0.0214	CbGbCtD
Dextroamphetamine—SLC6A2—Bupropion—obesity	0.00353	0.021	CbGbCtD
Dextroamphetamine—Amfecloral—Phentermine—obesity	0.00349	0.022	CrCrCtD
Dextroamphetamine—Tranylcypromine—Phentermine—obesity	0.00349	0.022	CrCrCtD
Dextroamphetamine—ADRA1A—Phenylpropanolamine—obesity	0.00343	0.0204	CbGbCtD
Dextroamphetamine—SLC6A2—Methamphetamine—obesity	0.00332	0.0198	CbGbCtD
Dextroamphetamine—Phenformin—Phentermine—obesity	0.00327	0.0207	CrCrCtD
Dextroamphetamine—Pseudoephedrine—Phenylpropanolamine—obesity	0.00326	0.0206	CrCrCtD
Dextroamphetamine—Ephedrine—Phenylpropanolamine—obesity	0.00326	0.0206	CrCrCtD
Dextroamphetamine—Selegiline—Diethylpropion—obesity	0.0032	0.0202	CrCrCtD
Dextroamphetamine—Amfecloral—Methamphetamine—obesity	0.00311	0.0197	CrCrCtD
Dextroamphetamine—Phenylpropanolamine—Phentermine—obesity	0.00308	0.0195	CrCrCtD
Dextroamphetamine—Tolazoline—Phentermine—obesity	0.00292	0.0184	CrCrCtD
Dextroamphetamine—Diethylpropion—Methamphetamine—obesity	0.00292	0.0184	CrCrCtD
Dextroamphetamine—Lisdexamfetamine—Methamphetamine—obesity	0.00292	0.0184	CrCrCtD
Dextroamphetamine—Phenformin—Methamphetamine—obesity	0.00292	0.0184	CrCrCtD
Dextroamphetamine—Phenol—Phenylpropanolamine—obesity	0.00284	0.018	CrCrCtD
Dextroamphetamine—Pseudoephedrine—Phentermine—obesity	0.00277	0.0175	CrCrCtD
Dextroamphetamine—Ephedrine—Phentermine—obesity	0.00277	0.0175	CrCrCtD
Dextroamphetamine—Lacosamide—Phentermine—obesity	0.00277	0.0175	CrCrCtD
Dextroamphetamine—Phenylpropanolamine—Methamphetamine—obesity	0.00275	0.0174	CrCrCtD
Dextroamphetamine—Phenelzine—Phenylpropanolamine—obesity	0.00273	0.0172	CrCrCtD
Dextroamphetamine—Selegiline—Phentermine—obesity	0.00264	0.0167	CrCrCtD
Dextroamphetamine—Phentermine—Phenylpropanolamine—obesity	0.00262	0.0166	CrCrCtD
Dextroamphetamine—Tolazoline—Methamphetamine—obesity	0.0026	0.0164	CrCrCtD
Dextroamphetamine—Nateglinide—Methamphetamine—obesity	0.0026	0.0164	CrCrCtD
Dextroamphetamine—Pargyline—Phentermine—obesity	0.00252	0.0159	CrCrCtD
Dextroamphetamine—Fenproporex—Phentermine—obesity	0.00252	0.0159	CrCrCtD
Dextroamphetamine—Bethanidine—Phentermine—obesity	0.00252	0.0159	CrCrCtD
Dextroamphetamine—Aspartame—Methamphetamine—obesity	0.00247	0.0156	CrCrCtD
Dextroamphetamine—Pseudoephedrine—Methamphetamine—obesity	0.00247	0.0156	CrCrCtD
Dextroamphetamine—Ephedrine—Methamphetamine—obesity	0.00247	0.0156	CrCrCtD
Dextroamphetamine—Lacosamide—Methamphetamine—obesity	0.00247	0.0156	CrCrCtD
Dextroamphetamine—Benzyl alcohol—Phenylpropanolamine—obesity	0.00244	0.0154	CrCrCtD
Dextroamphetamine—Phenol—Phentermine—obesity	0.00241	0.0153	CrCrCtD
Dextroamphetamine—Mephentermine—Phentermine—obesity	0.00241	0.0153	CrCrCtD
Dextroamphetamine—Selegiline—Methamphetamine—obesity	0.00235	0.0149	CrCrCtD
Dextroamphetamine—Phenelzine—Phentermine—obesity	0.00232	0.0147	CrCrCtD
Dextroamphetamine—Fenproporex—Methamphetamine—obesity	0.00225	0.0142	CrCrCtD
Dextroamphetamine—Pargyline—Methamphetamine—obesity	0.00225	0.0142	CrCrCtD
Dextroamphetamine—Bethanidine—Methamphetamine—obesity	0.00225	0.0142	CrCrCtD
Dextroamphetamine—Amphetamine—Diethylpropion—obesity	0.00221	0.014	CrCrCtD
Dextroamphetamine—Mephentermine—Methamphetamine—obesity	0.00215	0.0136	CrCrCtD
Dextroamphetamine—Phenol—Methamphetamine—obesity	0.00215	0.0136	CrCrCtD
Dextroamphetamine—Methamphetamine—Diethylpropion—obesity	0.00214	0.0136	CrCrCtD
Dextroamphetamine—Amphetamine—Phenylpropanolamine—obesity	0.00214	0.0136	CrCrCtD
Dextroamphetamine—Methamphetamine—Phenylpropanolamine—obesity	0.00208	0.0132	CrCrCtD
Dextroamphetamine—Benzyl alcohol—Phentermine—obesity	0.00207	0.0131	CrCrCtD
Dextroamphetamine—Phenelzine—Methamphetamine—obesity	0.00207	0.0131	CrCrCtD
Dextroamphetamine—Phentermine—Methamphetamine—obesity	0.00199	0.0126	CrCrCtD
Dextroamphetamine—Phenacemide—Phentermine—obesity	0.00188	0.0119	CrCrCtD
Dextroamphetamine—Selegiline—Benzphetamine—obesity	0.00187	0.0118	CrCrCtD
Dextroamphetamine—Benzyl alcohol—Methamphetamine—obesity	0.00185	0.0117	CrCrCtD
Dextroamphetamine—Amphetamine—Phentermine—obesity	0.00182	0.0115	CrCrCtD
Dextroamphetamine—Monobenzone—Benzphetamine—obesity	0.00178	0.0113	CrCrCtD
Dextroamphetamine—Pargyline—Benzphetamine—obesity	0.00178	0.0113	CrCrCtD
Dextroamphetamine—Fenproporex—Benzphetamine—obesity	0.00178	0.0113	CrCrCtD
Dextroamphetamine—Methamphetamine—Phentermine—obesity	0.00177	0.0112	CrCrCtD
Dextroamphetamine—L-Phenylalanine—Diethylpropion—obesity	0.00168	0.0106	CrCrCtD
Dextroamphetamine—Phenacemide—Methamphetamine—obesity	0.00167	0.0106	CrCrCtD
Dextroamphetamine—L-Phenylalanine—Phenylpropanolamine—obesity	0.00163	0.0103	CrCrCtD
Dextroamphetamine—Amphetamine—Methamphetamine—obesity	0.00162	0.0103	CrCrCtD
Dextroamphetamine—L-Phenylalanine—Phentermine—obesity	0.00139	0.00877	CrCrCtD
Dextroamphetamine—Amphetamine—Benzphetamine—obesity	0.00129	0.00815	CrCrCtD
Dextroamphetamine—Methamphetamine—Benzphetamine—obesity	0.00125	0.00791	CrCrCtD
Dextroamphetamine—CYP2D6—Phentermine—obesity	0.00125	0.00741	CbGbCtD
Dextroamphetamine—L-Phenylalanine—Methamphetamine—obesity	0.00124	0.00781	CrCrCtD
Dextroamphetamine—CYP2D6—Bupropion—obesity	0.00106	0.0063	CbGbCtD
Dextroamphetamine—CYP2D6—Methamphetamine—obesity	0.000996	0.00592	CbGbCtD
Dextroamphetamine—Benzphetamine—Methamphetamine—obesity	0.000992	0.00627	CrCrCtD
Dextroamphetamine—CYP2D6—Cimetidine—obesity	0.000778	0.00462	CbGbCtD
Dextroamphetamine—SLC6A2—sympathetic nervous system—obesity	0.000744	0.188	CbGeAlD
Dextroamphetamine—TAAR1—respiratory system—obesity	0.00062	0.156	CbGeAlD
Dextroamphetamine—SLC6A2—autonomic nervous system—obesity	0.0005	0.126	CbGeAlD
Dextroamphetamine—SLC6A3—hindbrain—obesity	0.000261	0.0659	CbGeAlD
Dextroamphetamine—ADRA1A—hindbrain—obesity	0.000196	0.0494	CbGeAlD
Dextroamphetamine—SLC6A3—respiratory system—obesity	0.000159	0.0402	CbGeAlD
Dextroamphetamine—SLC18A2—adipose tissue—obesity	0.000142	0.0359	CbGeAlD
Dextroamphetamine—SLC18A2—digestive system—obesity	0.000134	0.0338	CbGeAlD
Dextroamphetamine—Phenelzine—GPT—obesity	0.00013	0.152	CrCbGaD
Dextroamphetamine—SLC6A2—respiratory system—obesity	0.000129	0.0324	CbGeAlD
Dextroamphetamine—SLC18A2—adrenal gland—obesity	0.000128	0.0322	CbGeAlD
Dextroamphetamine—CYP2D6—hindbrain—obesity	0.000115	0.0291	CbGeAlD
Dextroamphetamine—SLC18A2—endocrine gland—obesity	0.000111	0.0279	CbGeAlD
Dextroamphetamine—Lacosamide—CA3—obesity	0.000109	0.127	CrCbGaD
Dextroamphetamine—Amphetamine—CARTPT—obesity	0.000104	0.122	CrCbGaD
Dextroamphetamine—SLC18A2—liver—obesity	9.98e-05	0.0252	CbGeAlD
Dextroamphetamine—ADRA1A—cardiovascular system—obesity	9.16e-05	0.0231	CbGeAlD
Dextroamphetamine—Aspartame—TRPV1—obesity	8.56e-05	0.0999	CrCbGaD
Dextroamphetamine—Phenelzine—AOC3—obesity	8.39e-05	0.098	CrCbGaD
Dextroamphetamine—ADRA1A—adipose tissue—obesity	8.08e-05	0.0204	CbGeAlD
Dextroamphetamine—SLC6A2—adrenal gland—obesity	7.79e-05	0.0197	CbGeAlD
Dextroamphetamine—ADRA1A—adrenal gland—obesity	7.25e-05	0.0183	CbGeAlD
Dextroamphetamine—SLC6A2—endocrine gland—obesity	6.76e-05	0.017	CbGeAlD
Dextroamphetamine—ADRA1A—endocrine gland—obesity	6.28e-05	0.0158	CbGeAlD
Dextroamphetamine—Constipation—Phenylpropanolamine—obesity	6.16e-05	0.00174	CcSEcCtD
Dextroamphetamine—Disturbance in sexual arousal—Sibutramine—obesity	6.15e-05	0.00174	CcSEcCtD
Dextroamphetamine—Dizziness—Benzphetamine—obesity	6.11e-05	0.00173	CcSEcCtD
Dextroamphetamine—Dry mouth—Diethylpropion—obesity	6.11e-05	0.00173	CcSEcCtD
Dextroamphetamine—Affect lability—Sibutramine—obesity	6.1e-05	0.00173	CcSEcCtD
Dextroamphetamine—Dyspepsia—Phentermine—obesity	6.06e-05	0.00171	CcSEcCtD
Dextroamphetamine—Psychotic disorder—Sibutramine—obesity	6.05e-05	0.00171	CcSEcCtD
Dextroamphetamine—Headache—Methamphetamine—obesity	6.01e-05	0.0017	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Phentermine—obesity	5.95e-05	0.00168	CcSEcCtD
Dextroamphetamine—Fatigue—Phentermine—obesity	5.94e-05	0.00168	CcSEcCtD
Dextroamphetamine—Anxiety—Cimetidine—obesity	5.93e-05	0.00168	CcSEcCtD
Dextroamphetamine—Constipation—Phentermine—obesity	5.89e-05	0.00167	CcSEcCtD
Dextroamphetamine—Injury—Bupropion—obesity	5.88e-05	0.00166	CcSEcCtD
Dextroamphetamine—Mood swings—Sibutramine—obesity	5.87e-05	0.00166	CcSEcCtD
Dextroamphetamine—Abdominal pain upper—Orlistat—obesity	5.85e-05	0.00165	CcSEcCtD
Dextroamphetamine—Tachycardia—Diethylpropion—obesity	5.85e-05	0.00165	CcSEcCtD
Dextroamphetamine—Libido decreased—Bupropion—obesity	5.83e-05	0.00165	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Diethylpropion—obesity	5.79e-05	0.00164	CcSEcCtD
Dextroamphetamine—Headache—Benzphetamine—obesity	5.79e-05	0.00164	CcSEcCtD
Dextroamphetamine—Diarrhoea—Phendimetrazine—obesity	5.77e-05	0.00163	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Cimetidine—obesity	5.7e-05	0.00161	CcSEcCtD
Dextroamphetamine—ADRA1A—liver—obesity	5.66e-05	0.0143	CbGeAlD
Dextroamphetamine—Dizziness—Phendimetrazine—obesity	5.57e-05	0.00158	CcSEcCtD
Dextroamphetamine—Tachycardia—Cimetidine—obesity	5.56e-05	0.00157	CcSEcCtD
Dextroamphetamine—Cerebrovascular accident—Bupropion—obesity	5.51e-05	0.00156	CcSEcCtD
Dextroamphetamine—Speech disorder—Topiramate—obesity	5.51e-05	0.00156	CcSEcCtD
Dextroamphetamine—Nausea—Benzphetamine—obesity	5.49e-05	0.00155	CcSEcCtD
Dextroamphetamine—Urticaria—Phentermine—obesity	5.47e-05	0.00155	CcSEcCtD
Dextroamphetamine—Abdominal pain—Phentermine—obesity	5.45e-05	0.00154	CcSEcCtD
Dextroamphetamine—Insomnia—Diethylpropion—obesity	5.42e-05	0.00153	CcSEcCtD
Dextroamphetamine—Disturbance in sexual arousal—Bupropion—obesity	5.36e-05	0.00152	CcSEcCtD
Dextroamphetamine—Dyspnoea—Diethylpropion—obesity	5.34e-05	0.00151	CcSEcCtD
Dextroamphetamine—Somnolence—Diethylpropion—obesity	5.33e-05	0.00151	CcSEcCtD
Dextroamphetamine—Affect lability—Bupropion—obesity	5.32e-05	0.0015	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Phenylpropanolamine—obesity	5.3e-05	0.0015	CcSEcCtD
Dextroamphetamine—Headache—Phendimetrazine—obesity	5.28e-05	0.00149	CcSEcCtD
Dextroamphetamine—Psychotic disorder—Bupropion—obesity	5.28e-05	0.00149	CcSEcCtD
Dextroamphetamine—Dyspepsia—Diethylpropion—obesity	5.27e-05	0.00149	CcSEcCtD
Dextroamphetamine—Viral infection—Topiramate—obesity	5.25e-05	0.00148	CcSEcCtD
Dextroamphetamine—Dysmenorrhoea—Topiramate—obesity	5.22e-05	0.00147	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Diethylpropion—obesity	5.17e-05	0.00146	CcSEcCtD
Dextroamphetamine—Irritability—Bupropion—obesity	5.16e-05	0.00146	CcSEcCtD
Dextroamphetamine—Constipation—Diethylpropion—obesity	5.12e-05	0.00145	CcSEcCtD
Dextroamphetamine—Mood swings—Bupropion—obesity	5.12e-05	0.00145	CcSEcCtD
Dextroamphetamine—Somnolence—Cimetidine—obesity	5.07e-05	0.00143	CcSEcCtD
Dextroamphetamine—Dyskinesia—Topiramate—obesity	5.05e-05	0.00143	CcSEcCtD
Dextroamphetamine—Nausea—Phendimetrazine—obesity	5.01e-05	0.00142	CcSEcCtD
Dextroamphetamine—Asthenia—Phentermine—obesity	4.94e-05	0.0014	CcSEcCtD
Dextroamphetamine—Abdominal pain upper—Bupropion—obesity	4.94e-05	0.0014	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Sibutramine—obesity	4.93e-05	0.0014	CcSEcCtD
Dextroamphetamine—Depression—Orlistat—obesity	4.92e-05	0.00139	CcSEcCtD
Dextroamphetamine—Fatigue—Cimetidine—obesity	4.92e-05	0.00139	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Sibutramine—obesity	4.89e-05	0.00138	CcSEcCtD
Dextroamphetamine—Constipation—Cimetidine—obesity	4.88e-05	0.00138	CcSEcCtD
Dextroamphetamine—Muscle twitching—Topiramate—obesity	4.83e-05	0.00137	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Orlistat—obesity	4.8e-05	0.00136	CcSEcCtD
Dextroamphetamine—Depression—Sibutramine—obesity	4.76e-05	0.00135	CcSEcCtD
Dextroamphetamine—Urticaria—Diethylpropion—obesity	4.76e-05	0.00135	CcSEcCtD
Dextroamphetamine—Dizziness—Phenylpropanolamine—obesity	4.76e-05	0.00135	CcSEcCtD
Dextroamphetamine—Diarrhoea—Phentermine—obesity	4.71e-05	0.00133	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Sibutramine—obesity	4.71e-05	0.00133	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Sibutramine—obesity	4.68e-05	0.00132	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Sibutramine—obesity	4.64e-05	0.00131	CcSEcCtD
Dextroamphetamine—Sweating—Sibutramine—obesity	4.58e-05	0.00129	CcSEcCtD
Dextroamphetamine—Vomiting—Phenylpropanolamine—obesity	4.58e-05	0.00129	CcSEcCtD
Dextroamphetamine—Dizziness—Phentermine—obesity	4.56e-05	0.00129	CcSEcCtD
Dextroamphetamine—Rash—Phenylpropanolamine—obesity	4.54e-05	0.00128	CcSEcCtD
Dextroamphetamine—Dermatitis—Phenylpropanolamine—obesity	4.53e-05	0.00128	CcSEcCtD
Dextroamphetamine—Body temperature increased—Cimetidine—obesity	4.51e-05	0.00127	CcSEcCtD
Dextroamphetamine—CYP2D6—digestive system—obesity	4.48e-05	0.0113	CbGeAlD
Dextroamphetamine—Vomiting—Phentermine—obesity	4.38e-05	0.00124	CcSEcCtD
Dextroamphetamine—Rash—Phentermine—obesity	4.34e-05	0.00123	CcSEcCtD
Dextroamphetamine—Dermatitis—Phentermine—obesity	4.34e-05	0.00123	CcSEcCtD
Dextroamphetamine—Headache—Phentermine—obesity	4.32e-05	0.00122	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Bupropion—obesity	4.3e-05	0.00122	CcSEcCtD
Dextroamphetamine—Nausea—Phenylpropanolamine—obesity	4.28e-05	0.00121	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Bupropion—obesity	4.26e-05	0.00121	CcSEcCtD
Dextroamphetamine—Weight decreased—Bupropion—obesity	4.23e-05	0.00119	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Cimetidine—obesity	4.2e-05	0.00119	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Bupropion—obesity	4.13e-05	0.00117	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Bupropion—obesity	4.11e-05	0.00116	CcSEcCtD
Dextroamphetamine—Diarrhoea—Diethylpropion—obesity	4.1e-05	0.00116	CcSEcCtD
Dextroamphetamine—Nausea—Phentermine—obesity	4.09e-05	0.00116	CcSEcCtD
Dextroamphetamine—Asthenia—Cimetidine—obesity	4.09e-05	0.00116	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Bupropion—obesity	4.08e-05	0.00115	CcSEcCtD
Dextroamphetamine—Euphoric mood—Topiramate—obesity	4.07e-05	0.00115	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Bupropion—obesity	4.05e-05	0.00114	CcSEcCtD
Dextroamphetamine—Sweating—Bupropion—obesity	3.99e-05	0.00113	CcSEcCtD
Dextroamphetamine—Dizziness—Diethylpropion—obesity	3.96e-05	0.00112	CcSEcCtD
Dextroamphetamine—Diarrhoea—Cimetidine—obesity	3.9e-05	0.0011	CcSEcCtD
Dextroamphetamine—Phenformin—SLC22A1—obesity	3.81e-05	0.0445	CrCbGaD
Dextroamphetamine—Vomiting—Diethylpropion—obesity	3.81e-05	0.00108	CcSEcCtD
Dextroamphetamine—Rash—Diethylpropion—obesity	3.78e-05	0.00107	CcSEcCtD
Dextroamphetamine—Dermatitis—Diethylpropion—obesity	3.77e-05	0.00107	CcSEcCtD
Dextroamphetamine—Dizziness—Cimetidine—obesity	3.77e-05	0.00107	CcSEcCtD
Dextroamphetamine—Headache—Diethylpropion—obesity	3.75e-05	0.00106	CcSEcCtD
Dextroamphetamine—Libido decreased—Topiramate—obesity	3.71e-05	0.00105	CcSEcCtD
Dextroamphetamine—CYP2D6—endocrine gland—obesity	3.7e-05	0.00933	CbGeAlD
Dextroamphetamine—Tension—Sibutramine—obesity	3.66e-05	0.00104	CcSEcCtD
Dextroamphetamine—Nervousness—Sibutramine—obesity	3.63e-05	0.00103	CcSEcCtD
Dextroamphetamine—Vomiting—Cimetidine—obesity	3.63e-05	0.00103	CcSEcCtD
Dextroamphetamine—Rash—Cimetidine—obesity	3.6e-05	0.00102	CcSEcCtD
Dextroamphetamine—Dermatitis—Cimetidine—obesity	3.59e-05	0.00102	CcSEcCtD
Dextroamphetamine—Headache—Cimetidine—obesity	3.57e-05	0.00101	CcSEcCtD
Dextroamphetamine—Nausea—Diethylpropion—obesity	3.56e-05	0.00101	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Bupropion—obesity	3.53e-05	0.000999	CcSEcCtD
Dextroamphetamine—Angioedema—Orlistat—obesity	3.52e-05	0.000997	CcSEcCtD
Dextroamphetamine—Tremor—Sibutramine—obesity	3.5e-05	0.000989	CcSEcCtD
Dextroamphetamine—Agitation—Sibutramine—obesity	3.43e-05	0.00097	CcSEcCtD
Dextroamphetamine—Disturbance in sexual arousal—Topiramate—obesity	3.42e-05	0.000966	CcSEcCtD
Dextroamphetamine—Angioedema—Sibutramine—obesity	3.41e-05	0.000964	CcSEcCtD
Dextroamphetamine—Palpitations—Orlistat—obesity	3.41e-05	0.000964	CcSEcCtD
Dextroamphetamine—Affect lability—Topiramate—obesity	3.39e-05	0.000958	CcSEcCtD
Dextroamphetamine—Nausea—Cimetidine—obesity	3.39e-05	0.000958	CcSEcCtD
Dextroamphetamine—Psychotic disorder—Topiramate—obesity	3.36e-05	0.000951	CcSEcCtD
Dextroamphetamine—Convulsion—Orlistat—obesity	3.34e-05	0.000945	CcSEcCtD
Dextroamphetamine—CYP2D6—liver—obesity	3.34e-05	0.00842	CbGeAlD
Dextroamphetamine—Palpitations—Sibutramine—obesity	3.3e-05	0.000933	CcSEcCtD
Dextroamphetamine—Irritability—Topiramate—obesity	3.29e-05	0.000929	CcSEcCtD
Dextroamphetamine—Chest pain—Orlistat—obesity	3.28e-05	0.000929	CcSEcCtD
Dextroamphetamine—Anxiety—Orlistat—obesity	3.27e-05	0.000925	CcSEcCtD
Dextroamphetamine—Mood swings—Topiramate—obesity	3.26e-05	0.000922	CcSEcCtD
Dextroamphetamine—Convulsion—Sibutramine—obesity	3.23e-05	0.000915	CcSEcCtD
Dextroamphetamine—Hypertension—Sibutramine—obesity	3.22e-05	0.000911	CcSEcCtD
Dextroamphetamine—Dry mouth—Orlistat—obesity	3.21e-05	0.000908	CcSEcCtD
Dextroamphetamine—Tension—Bupropion—obesity	3.19e-05	0.000903	CcSEcCtD
Dextroamphetamine—Chest pain—Sibutramine—obesity	3.18e-05	0.000899	CcSEcCtD
Dextroamphetamine—Anxiety—Sibutramine—obesity	3.17e-05	0.000896	CcSEcCtD
Dextroamphetamine—Nervousness—Bupropion—obesity	3.16e-05	0.000894	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Orlistat—obesity	3.15e-05	0.00089	CcSEcCtD
Dextroamphetamine—Abdominal pain upper—Topiramate—obesity	3.14e-05	0.000889	CcSEcCtD
Dextroamphetamine—Infection—Orlistat—obesity	3.13e-05	0.000884	CcSEcCtD
Dextroamphetamine—Dry mouth—Sibutramine—obesity	3.11e-05	0.000879	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Topiramate—obesity	3.1e-05	0.000877	CcSEcCtD
Dextroamphetamine—Tremor—Bupropion—obesity	3.05e-05	0.000862	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Sibutramine—obesity	3.05e-05	0.000861	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Orlistat—obesity	3.04e-05	0.00086	CcSEcCtD
Dextroamphetamine—Infection—Sibutramine—obesity	3.03e-05	0.000856	CcSEcCtD
Dextroamphetamine—Agitation—Bupropion—obesity	2.99e-05	0.000846	CcSEcCtD
Dextroamphetamine—Angioedema—Bupropion—obesity	2.97e-05	0.000841	CcSEcCtD
Dextroamphetamine—Tachycardia—Sibutramine—obesity	2.97e-05	0.000841	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Sibutramine—obesity	2.95e-05	0.000833	CcSEcCtD
Dextroamphetamine—Anorexia—Sibutramine—obesity	2.9e-05	0.000821	CcSEcCtD
Dextroamphetamine—Palpitations—Bupropion—obesity	2.88e-05	0.000813	CcSEcCtD
Dextroamphetamine—Insomnia—Orlistat—obesity	2.85e-05	0.000805	CcSEcCtD
Dextroamphetamine—Convulsion—Bupropion—obesity	2.82e-05	0.000797	CcSEcCtD
Dextroamphetamine—Hypertension—Bupropion—obesity	2.81e-05	0.000794	CcSEcCtD
Dextroamphetamine—Dyspepsia—Orlistat—obesity	2.77e-05	0.000784	CcSEcCtD
Dextroamphetamine—Chest pain—Bupropion—obesity	2.77e-05	0.000783	CcSEcCtD
Dextroamphetamine—Anxiety—Bupropion—obesity	2.76e-05	0.000781	CcSEcCtD
Dextroamphetamine—Insomnia—Sibutramine—obesity	2.76e-05	0.000779	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Topiramate—obesity	2.74e-05	0.000775	CcSEcCtD
Dextroamphetamine—Decreased appetite—Orlistat—obesity	2.74e-05	0.000774	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Orlistat—obesity	2.72e-05	0.000768	CcSEcCtD
Dextroamphetamine—Dyspnoea—Sibutramine—obesity	2.72e-05	0.000768	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Topiramate—obesity	2.72e-05	0.000768	CcSEcCtD
Dextroamphetamine—Fatigue—Orlistat—obesity	2.71e-05	0.000767	CcSEcCtD
Dextroamphetamine—Dry mouth—Bupropion—obesity	2.71e-05	0.000766	CcSEcCtD
Dextroamphetamine—Somnolence—Sibutramine—obesity	2.71e-05	0.000766	CcSEcCtD
Dextroamphetamine—Weight decreased—Topiramate—obesity	2.69e-05	0.000761	CcSEcCtD
Dextroamphetamine—Dyspepsia—Sibutramine—obesity	2.68e-05	0.000758	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Bupropion—obesity	2.66e-05	0.000751	CcSEcCtD
Dextroamphetamine—Decreased appetite—Sibutramine—obesity	2.65e-05	0.000749	CcSEcCtD
Dextroamphetamine—Depression—Topiramate—obesity	2.65e-05	0.000748	CcSEcCtD
Dextroamphetamine—Infection—Bupropion—obesity	2.64e-05	0.000746	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Topiramate—obesity	2.63e-05	0.000744	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Sibutramine—obesity	2.63e-05	0.000744	CcSEcCtD
Dextroamphetamine—Constipation—Sibutramine—obesity	2.61e-05	0.000737	CcSEcCtD
Dextroamphetamine—Tachycardia—Bupropion—obesity	2.59e-05	0.000733	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Topiramate—obesity	2.58e-05	0.000729	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Orlistat—obesity	2.57e-05	0.000728	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Bupropion—obesity	2.57e-05	0.000726	CcSEcCtD
Dextroamphetamine—Anorexia—Bupropion—obesity	2.53e-05	0.000716	CcSEcCtD
Dextroamphetamine—Urticaria—Orlistat—obesity	2.5e-05	0.000707	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Sibutramine—obesity	2.49e-05	0.000704	CcSEcCtD
Dextroamphetamine—Abdominal pain—Orlistat—obesity	2.49e-05	0.000704	CcSEcCtD
Dextroamphetamine—Body temperature increased—Orlistat—obesity	2.49e-05	0.000704	CcSEcCtD
Dextroamphetamine—Urticaria—Sibutramine—obesity	2.42e-05	0.000684	CcSEcCtD
Dextroamphetamine—Ephedrine—BCHE—obesity	2.42e-05	0.0282	CrCbGaD
Dextroamphetamine—Body temperature increased—Sibutramine—obesity	2.41e-05	0.000681	CcSEcCtD
Dextroamphetamine—Abdominal pain—Sibutramine—obesity	2.41e-05	0.000681	CcSEcCtD
Dextroamphetamine—Insomnia—Bupropion—obesity	2.4e-05	0.000679	CcSEcCtD
Dextroamphetamine—Phenylpropanolamine—DRD1—obesity	2.39e-05	0.0279	CrCbGaD
Dextroamphetamine—Dyspnoea—Bupropion—obesity	2.37e-05	0.00067	CcSEcCtD
Dextroamphetamine—Somnolence—Bupropion—obesity	2.36e-05	0.000668	CcSEcCtD
Dextroamphetamine—Dyspepsia—Bupropion—obesity	2.34e-05	0.000661	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Orlistat—obesity	2.32e-05	0.000656	CcSEcCtD
Dextroamphetamine—Decreased appetite—Bupropion—obesity	2.31e-05	0.000653	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Bupropion—obesity	2.29e-05	0.000648	CcSEcCtD
Dextroamphetamine—Fatigue—Bupropion—obesity	2.29e-05	0.000647	CcSEcCtD
Dextroamphetamine—Constipation—Bupropion—obesity	2.27e-05	0.000642	CcSEcCtD
Dextroamphetamine—Asthenia—Orlistat—obesity	2.26e-05	0.000639	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Topiramate—obesity	2.25e-05	0.000637	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Sibutramine—obesity	2.24e-05	0.000635	CcSEcCtD
Dextroamphetamine—Phenylpropanolamine—ADRB1—obesity	2.22e-05	0.0259	CrCbGaD
Dextroamphetamine—Asthenia—Sibutramine—obesity	2.19e-05	0.000618	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Bupropion—obesity	2.17e-05	0.000614	CcSEcCtD
Dextroamphetamine—Diarrhoea—Orlistat—obesity	2.15e-05	0.000609	CcSEcCtD
Dextroamphetamine—Urticaria—Bupropion—obesity	2.11e-05	0.000597	CcSEcCtD
Dextroamphetamine—Abdominal pain—Bupropion—obesity	2.1e-05	0.000594	CcSEcCtD
Dextroamphetamine—Body temperature increased—Bupropion—obesity	2.1e-05	0.000594	CcSEcCtD
Dextroamphetamine—Diarrhoea—Sibutramine—obesity	2.08e-05	0.000589	CcSEcCtD
Dextroamphetamine—Dizziness—Orlistat—obesity	2.08e-05	0.000589	CcSEcCtD
Dextroamphetamine—Ephedrine—ADRB2—obesity	2.08e-05	0.0243	CrCbGaD
Dextroamphetamine—Tension—Topiramate—obesity	2.03e-05	0.000575	CcSEcCtD
Dextroamphetamine—Dizziness—Sibutramine—obesity	2.01e-05	0.00057	CcSEcCtD
Dextroamphetamine—Nervousness—Topiramate—obesity	2.01e-05	0.000569	CcSEcCtD
Dextroamphetamine—Vomiting—Orlistat—obesity	2e-05	0.000566	CcSEcCtD
Dextroamphetamine—Rash—Orlistat—obesity	1.98e-05	0.000561	CcSEcCtD
Dextroamphetamine—Dermatitis—Orlistat—obesity	1.98e-05	0.000561	CcSEcCtD
Dextroamphetamine—Headache—Orlistat—obesity	1.97e-05	0.000558	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Bupropion—obesity	1.96e-05	0.000553	CcSEcCtD
Dextroamphetamine—Tremor—Topiramate—obesity	1.94e-05	0.000549	CcSEcCtD
Dextroamphetamine—Vomiting—Sibutramine—obesity	1.94e-05	0.000548	CcSEcCtD
Dextroamphetamine—Rash—Sibutramine—obesity	1.92e-05	0.000543	CcSEcCtD
Dextroamphetamine—Dermatitis—Sibutramine—obesity	1.92e-05	0.000543	CcSEcCtD
Dextroamphetamine—Headache—Sibutramine—obesity	1.91e-05	0.00054	CcSEcCtD
Dextroamphetamine—Asthenia—Bupropion—obesity	1.91e-05	0.000539	CcSEcCtD
Dextroamphetamine—Agitation—Topiramate—obesity	1.91e-05	0.000539	CcSEcCtD
Dextroamphetamine—Pseudoephedrine—ADRB1—obesity	1.88e-05	0.0219	CrCbGaD
Dextroamphetamine—Nausea—Orlistat—obesity	1.87e-05	0.000529	CcSEcCtD
Dextroamphetamine—Phenylpropanolamine—ADRB2—obesity	1.87e-05	0.0218	CrCbGaD
Dextroamphetamine—Palpitations—Topiramate—obesity	1.83e-05	0.000518	CcSEcCtD
Dextroamphetamine—Diarrhoea—Bupropion—obesity	1.82e-05	0.000514	CcSEcCtD
Dextroamphetamine—Nausea—Sibutramine—obesity	1.81e-05	0.000512	CcSEcCtD
Dextroamphetamine—Convulsion—Topiramate—obesity	1.8e-05	0.000508	CcSEcCtD
Dextroamphetamine—Hypertension—Topiramate—obesity	1.79e-05	0.000506	CcSEcCtD
Dextroamphetamine—Pseudoephedrine—TNF—obesity	1.78e-05	0.0208	CrCbGaD
Dextroamphetamine—Chest pain—Topiramate—obesity	1.77e-05	0.000499	CcSEcCtD
Dextroamphetamine—Anxiety—Topiramate—obesity	1.76e-05	0.000497	CcSEcCtD
Dextroamphetamine—Dizziness—Bupropion—obesity	1.76e-05	0.000497	CcSEcCtD
Dextroamphetamine—Nateglinide—PPARG—obesity	1.75e-05	0.0204	CrCbGaD
Dextroamphetamine—Dry mouth—Topiramate—obesity	1.73e-05	0.000488	CcSEcCtD
Dextroamphetamine—Tranylcypromine—CYP2E1—obesity	1.73e-05	0.0201	CrCbGaD
Dextroamphetamine—Vomiting—Bupropion—obesity	1.69e-05	0.000477	CcSEcCtD
Dextroamphetamine—Infection—Topiramate—obesity	1.68e-05	0.000475	CcSEcCtD
Dextroamphetamine—Rash—Bupropion—obesity	1.67e-05	0.000474	CcSEcCtD
Dextroamphetamine—Dermatitis—Bupropion—obesity	1.67e-05	0.000473	CcSEcCtD
Dextroamphetamine—Headache—Bupropion—obesity	1.66e-05	0.00047	CcSEcCtD
Dextroamphetamine—Tachycardia—Topiramate—obesity	1.65e-05	0.000467	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Topiramate—obesity	1.64e-05	0.000463	CcSEcCtD
Dextroamphetamine—Anorexia—Topiramate—obesity	1.61e-05	0.000456	CcSEcCtD
Dextroamphetamine—Nausea—Bupropion—obesity	1.58e-05	0.000446	CcSEcCtD
Dextroamphetamine—Pseudoephedrine—ADRB2—obesity	1.58e-05	0.0184	CrCbGaD
Dextroamphetamine—Insomnia—Topiramate—obesity	1.53e-05	0.000433	CcSEcCtD
Dextroamphetamine—Phentermine—SLC6A4—obesity	1.51e-05	0.0176	CrCbGaD
Dextroamphetamine—Dyspnoea—Topiramate—obesity	1.51e-05	0.000427	CcSEcCtD
Dextroamphetamine—Somnolence—Topiramate—obesity	1.5e-05	0.000425	CcSEcCtD
Dextroamphetamine—Dyspepsia—Topiramate—obesity	1.49e-05	0.000421	CcSEcCtD
Dextroamphetamine—Decreased appetite—Topiramate—obesity	1.47e-05	0.000416	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Topiramate—obesity	1.46e-05	0.000413	CcSEcCtD
Dextroamphetamine—Fatigue—Topiramate—obesity	1.46e-05	0.000413	CcSEcCtD
Dextroamphetamine—Constipation—Topiramate—obesity	1.45e-05	0.000409	CcSEcCtD
Dextroamphetamine—Pseudoephedrine—SLC6A4—obesity	1.43e-05	0.0167	CrCbGaD
Dextroamphetamine—Benzyl alcohol—CYP2E1—obesity	1.39e-05	0.0163	CrCbGaD
Dextroamphetamine—Gastrointestinal pain—Topiramate—obesity	1.38e-05	0.000391	CcSEcCtD
Dextroamphetamine—Urticaria—Topiramate—obesity	1.34e-05	0.00038	CcSEcCtD
Dextroamphetamine—Selegiline—CYP2E1—obesity	1.34e-05	0.0156	CrCbGaD
Dextroamphetamine—Abdominal pain—Topiramate—obesity	1.34e-05	0.000378	CcSEcCtD
Dextroamphetamine—Body temperature increased—Topiramate—obesity	1.34e-05	0.000378	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Topiramate—obesity	1.25e-05	0.000353	CcSEcCtD
Dextroamphetamine—Asthenia—Topiramate—obesity	1.21e-05	0.000343	CcSEcCtD
Dextroamphetamine—Phenelzine—CYP2E1—obesity	1.18e-05	0.0138	CrCbGaD
Dextroamphetamine—Amphetamine—SLC6A4—obesity	1.16e-05	0.0136	CrCbGaD
Dextroamphetamine—Diarrhoea—Topiramate—obesity	1.16e-05	0.000327	CcSEcCtD
Dextroamphetamine—Amphetamine—DRD2—obesity	1.16e-05	0.0135	CrCbGaD
Dextroamphetamine—Dizziness—Topiramate—obesity	1.12e-05	0.000316	CcSEcCtD
Dextroamphetamine—Methamphetamine—SLC6A4—obesity	1.08e-05	0.0126	CrCbGaD
Dextroamphetamine—Vomiting—Topiramate—obesity	1.08e-05	0.000304	CcSEcCtD
Dextroamphetamine—Rash—Topiramate—obesity	1.07e-05	0.000302	CcSEcCtD
Dextroamphetamine—Dermatitis—Topiramate—obesity	1.07e-05	0.000301	CcSEcCtD
Dextroamphetamine—Headache—Topiramate—obesity	1.06e-05	0.0003	CcSEcCtD
Dextroamphetamine—Nausea—Topiramate—obesity	1.01e-05	0.000284	CcSEcCtD
Dextroamphetamine—Nateglinide—ALB—obesity	6.57e-06	0.00767	CrCbGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IAPP—obesity	1.3e-06	6.58e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NTRK2—obesity	1.28e-06	6.5e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ACP5—obesity	1.28e-06	6.49e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADRB1—obesity	1.28e-06	6.47e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—AGT—obesity	1.27e-06	6.44e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CG—obesity	1.27e-06	6.41e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CRH—obesity	1.26e-06	6.39e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR1B—obesity	1.26e-06	6.39e-05	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PIK3CA—obesity	1.25e-06	6.35e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GHRL—obesity	1.25e-06	6.34e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PARP1—obesity	1.25e-06	6.34e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—G6PD—obesity	1.25e-06	6.32e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SDC1—obesity	1.25e-06	6.31e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PRKCD—obesity	1.24e-06	6.3e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—DRD4—obesity	1.24e-06	6.28e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HK1—obesity	1.23e-06	6.25e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SREBF2—obesity	1.23e-06	6.25e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AKR1C3—obesity	1.23e-06	6.21e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HTR2A—obesity	1.22e-06	6.16e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—C3—obesity	1.21e-06	6.16e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—POMC—obesity	1.2e-06	6.1e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PRKCB—obesity	1.2e-06	6.08e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—F2—obesity	1.2e-06	6.08e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NPS—obesity	1.19e-06	6.05e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—LPA—obesity	1.19e-06	6.03e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CNR1—obesity	1.18e-06	6e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PRKCB—obesity	1.17e-06	5.95e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—F2—obesity	1.17e-06	5.95e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR2C—obesity	1.17e-06	5.94e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—DRD1—obesity	1.17e-06	5.94e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—LPIN1—obesity	1.17e-06	5.9e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TCF7L2—obesity	1.16e-06	5.89e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—AKT2—obesity	1.16e-06	5.87e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—DRD2—obesity	1.16e-06	5.85e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AGT—obesity	1.15e-06	5.85e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CG—obesity	1.15e-06	5.82e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GCG—obesity	1.14e-06	5.79e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PTPN1—obesity	1.14e-06	5.79e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—APOA5—obesity	1.14e-06	5.78e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NTRK2—obesity	1.14e-06	5.77e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADRB1—obesity	1.13e-06	5.75e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CG—obesity	1.12e-06	5.7e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CD—obesity	1.11e-06	5.64e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GHRL—obesity	1.11e-06	5.63e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PARP1—obesity	1.11e-06	5.63e-05	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IL6—obesity	1.11e-06	5.62e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—DRD4—obesity	1.1e-06	5.58e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—POMC—obesity	1.09e-06	5.54e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PRL—obesity	1.09e-06	5.53e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CLOCK—obesity	1.09e-06	5.52e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SLC22A1—obesity	1.09e-06	5.52e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—STK11—obesity	1.08e-06	5.45e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCL2—obesity	1.07e-06	5.42e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—POMC—obesity	1.07e-06	5.42e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—F2—obesity	1.07e-06	5.4e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PRKCB—obesity	1.07e-06	5.4e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PLG—obesity	1.06e-06	5.39e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—RHOA—obesity	1.06e-06	5.38e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SULT2A1—obesity	1.06e-06	5.38e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GLP1R—obesity	1.06e-06	5.38e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CNR1—obesity	1.05e-06	5.33e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—AKT2—obesity	1.05e-06	5.33e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3R1—obesity	1.05e-06	5.32e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—DPYD—obesity	1.04e-06	5.29e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FOXO3—obesity	1.04e-06	5.26e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADRB2—obesity	1.03e-06	5.24e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TCF7L2—obesity	1.03e-06	5.24e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—AKT2—obesity	1.03e-06	5.21e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—DRD2—obesity	1.03e-06	5.2e-05	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—AKT1—obesity	1.02e-06	5.19e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CG—obesity	1.02e-06	5.17e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SOCS1—obesity	1.02e-06	5.16e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PTPN1—obesity	1.02e-06	5.15e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GCG—obesity	1.02e-06	5.15e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CD—obesity	1.01e-06	5.12e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SOCS3—obesity	1.01e-06	5.1e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PRKAR2B—obesity	1e-06	5.09e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—DCN—obesity	9.98e-07	5.06e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CD—obesity	9.88e-07	5.01e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GNB3—obesity	9.86e-07	4.99e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—TYK2—obesity	9.72e-07	4.92e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—POMC—obesity	9.72e-07	4.92e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CPT1A—obesity	9.71e-07	4.92e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CB—obesity	9.7e-07	4.91e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PRL—obesity	9.69e-07	4.91e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IGF2—obesity	9.68e-07	4.91e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—RHOA—obesity	9.64e-07	4.88e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GNAS—obesity	9.6e-07	4.86e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—STK11—obesity	9.55e-07	4.84e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3R1—obesity	9.54e-07	4.83e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NAMPT—obesity	9.52e-07	4.82e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCL2—obesity	9.51e-07	4.82e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GCK—obesity	9.46e-07	4.79e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—LIPC—obesity	9.46e-07	4.79e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PLG—obesity	9.44e-07	4.78e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—RHOA—obesity	9.43e-07	4.78e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—APOC3—obesity	9.4e-07	4.76e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APOB—obesity	9.4e-07	4.76e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AKT2—obesity	9.34e-07	4.73e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3R1—obesity	9.33e-07	4.73e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FOXO3—obesity	9.22e-07	4.67e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADRB2—obesity	9.19e-07	4.66e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCL5—obesity	9.18e-07	4.65e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CETP—obesity	9.12e-07	4.62e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SOCS1—obesity	9.05e-07	4.59e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SDC1—obesity	9.02e-07	4.57e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—LPL—obesity	8.97e-07	4.55e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CD—obesity	8.97e-07	4.55e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SOCS3—obesity	8.94e-07	4.53e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FOXO1—obesity	8.91e-07	4.51e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—RPS6KB1—obesity	8.89e-07	4.51e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—AKR1C3—obesity	8.88e-07	4.5e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CB—obesity	8.81e-07	4.46e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GNB3—obesity	8.76e-07	4.44e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SCARB1—obesity	8.74e-07	4.43e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—TYK2—obesity	8.63e-07	4.37e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CB—obesity	8.61e-07	4.36e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IGF2—obesity	8.6e-07	4.36e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—RHOA—obesity	8.56e-07	4.34e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GNAS—obesity	8.52e-07	4.32e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SREBF1—obesity	8.48e-07	4.3e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3R1—obesity	8.47e-07	4.29e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APOB—obesity	8.35e-07	4.23e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PRKCD—obesity	8.27e-07	4.19e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GOT2—obesity	8.25e-07	4.18e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCL5—obesity	8.15e-07	4.13e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HTR2A—obesity	8.09e-07	4.1e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—C3—obesity	8.08e-07	4.09e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—FASN—obesity	8.08e-07	4.09e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—BCHE—obesity	8.04e-07	4.07e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—LPL—obesity	7.97e-07	4.04e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FOXO1—obesity	7.91e-07	4.01e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RPS6KB1—obesity	7.9e-07	4e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CB—obesity	7.82e-07	3.96e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP2E1—obesity	7.76e-07	3.93e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IRS2—obesity	7.69e-07	3.89e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AGT—obesity	7.68e-07	3.89e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NQO1—obesity	7.67e-07	3.89e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APOE—obesity	7.52e-07	3.81e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—LEP—obesity	7.52e-07	3.81e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CAV1—obesity	7.45e-07	3.78e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APOA1—obesity	7.44e-07	3.77e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SLC2A4—obesity	7.36e-07	3.73e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GCG—obesity	7.36e-07	3.73e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PRKCD—obesity	7.34e-07	3.72e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYCS—obesity	7.26e-07	3.68e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR2A—obesity	7.19e-07	3.64e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ESR1—obesity	7.18e-07	3.64e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—C3—obesity	7.18e-07	3.64e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GOT1—obesity	7.12e-07	3.61e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GGT1—obesity	7.12e-07	3.61e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PRKCB—obesity	7.09e-07	3.59e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—F2—obesity	7.09e-07	3.59e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NCOA1—obesity	7.02e-07	3.56e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—BAD—obesity	7.01e-07	3.55e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—STK11—obesity	6.92e-07	3.5e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP19A1—obesity	6.92e-07	3.5e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IRS2—obesity	6.83e-07	3.46e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AGT—obesity	6.82e-07	3.46e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CG—obesity	6.79e-07	3.44e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IRS1—obesity	6.71e-07	3.4e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APOE—obesity	6.68e-07	3.39e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—LEP—obesity	6.68e-07	3.39e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CAV1—obesity	6.62e-07	3.35e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APOA1—obesity	6.6e-07	3.35e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—POMC—obesity	6.46e-07	3.27e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—COMT—obesity	6.43e-07	3.26e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—INS—obesity	6.43e-07	3.26e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ESR1—obesity	6.38e-07	3.23e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PPARGC1A—obesity	6.34e-07	3.21e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GNB3—obesity	6.34e-07	3.21e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCL2—obesity	6.32e-07	3.2e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HMOX1—obesity	6.31e-07	3.2e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—F2—obesity	6.3e-07	3.19e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PRKCB—obesity	6.3e-07	3.19e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—BAD—obesity	6.23e-07	3.15e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IGF1—obesity	6.22e-07	3.15e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AKT2—obesity	6.21e-07	3.15e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GNAS—obesity	6.17e-07	3.13e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—APOB—obesity	6.04e-07	3.06e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CG—obesity	6.03e-07	3.06e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CD—obesity	5.97e-07	3.02e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IRS1—obesity	5.96e-07	3.02e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CA—obesity	5.91e-07	3e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SERPINE1—obesity	5.9e-07	2.99e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—LPL—obesity	5.77e-07	2.92e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TYK2—obesity	5.74e-07	2.91e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—POMC—obesity	5.74e-07	2.91e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—INS—obesity	5.71e-07	2.89e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—RHOA—obesity	5.69e-07	2.89e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NOS3—obesity	5.64e-07	2.86e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3R1—obesity	5.64e-07	2.86e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GPX1—obesity	5.63e-07	2.85e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCL2—obesity	5.62e-07	2.85e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IGF1—obesity	5.52e-07	2.8e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AKT2—obesity	5.52e-07	2.8e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CD36—obesity	5.48e-07	2.78e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CA—obesity	5.37e-07	2.72e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CD—obesity	5.3e-07	2.69e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	5.25e-07	2.66e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SERPINE1—obesity	5.24e-07	2.66e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CB—obesity	5.2e-07	2.64e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MTOR—obesity	5.2e-07	2.64e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—MTHFR—obesity	5.2e-07	2.63e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TYK2—obesity	5.1e-07	2.58e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PPARA—obesity	5.1e-07	2.58e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RHOA—obesity	5.06e-07	2.56e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3R1—obesity	5.01e-07	2.54e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NOS3—obesity	5.01e-07	2.54e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—AGT—obesity	4.94e-07	2.5e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—APOE—obesity	4.84e-07	2.45e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—AKT1—obesity	4.83e-07	2.45e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CAV1—obesity	4.79e-07	2.43e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—APOA1—obesity	4.78e-07	2.42e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CA—obesity	4.77e-07	2.42e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL6—obesity	4.75e-07	2.41e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MTOR—obesity	4.62e-07	2.34e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CB—obesity	4.62e-07	2.34e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MMP9—obesity	4.52e-07	2.29e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MAPK8—obesity	4.4e-07	2.23e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—AKT1—obesity	4.39e-07	2.22e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CG—obesity	4.37e-07	2.21e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—AKT1—obesity	4.29e-07	2.17e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL6—obesity	4.22e-07	2.14e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PPARG—obesity	4.21e-07	2.14e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—POMC—obesity	4.16e-07	2.11e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—INS—obesity	4.13e-07	2.09e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—STAT3—obesity	4.02e-07	2.04e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MMP9—obesity	4.02e-07	2.03e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MAPK8—obesity	3.91e-07	1.98e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AKT1—obesity	3.9e-07	1.97e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CD—obesity	3.84e-07	1.94e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ALB—obesity	3.79e-07	1.92e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MYC—obesity	3.74e-07	1.89e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TGFB1—obesity	3.73e-07	1.89e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NOS3—obesity	3.62e-07	1.84e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3R1—obesity	3.62e-07	1.84e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—STAT3—obesity	3.57e-07	1.81e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CB—obesity	3.35e-07	1.7e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MYC—obesity	3.32e-07	1.68e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTGS2—obesity	3.31e-07	1.68e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TGFB1—obesity	3.31e-07	1.68e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CA—obesity	3.17e-07	1.61e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CA—obesity	2.82e-07	1.43e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL6—obesity	2.81e-07	1.42e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AKT1—obesity	2.59e-07	1.31e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL6—obesity	2.49e-07	1.26e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AKT1—obesity	2.3e-07	1.17e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CA—obesity	2.04e-07	1.03e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—AKT1—obesity	1.67e-07	8.44e-06	CbGpPWpGaD
